About

Our goal is to optimize value creation across all stages of our investment journey; from clinical trials and FDA approvals, through market validation and product adoption, to successful entry into capital markets and strategic deals.

Driving HealthTech from business plan to business success

Our unique strategic ecosystem and team’s active engagement help portfolio companies realize their full potential and achieve large-scale success. By providing unparalleled access to invaluable resources in the form of:

  • Clinical infrastructures
  • KOLs
  • Big data
  • Domain experts
  • Financial backing

We help our companies gain an in-depth understanding of clinical workflows and procedures, to ensure product-market fit under challenging health economics, deliver better care for patients and create value to all stake holders.

We invest in the right fit

We invest in promising mid-to-late stage companies developing innovative platform technologies that will become the gold standard in a broad range of disciplines.

The main areas of focus include:

  • Medical devices
  • Diagnostics
  • Digital health
  • Healthcare IT
  • AI and ML

We look for highly fundable companies with strong management, broad IP protection and a proven track record of execution, that are poised to benefit from the strategic synergies offered by the ALIVE ecosystem.

Similar companies

KR

KP Rx

Established in 2023, KP Rx is a 100% founder-owned investment firm specialising in private and early-stage public healthcare investments in Australia and New Zealand. Founded by Hashan De Silva and backed by Karst Peak Capital, the firm targets high-potential biotech, medical devices, diagnostics, and health tech companies at a pivotal inflection point of value creation. Our Focus Creating a portfolio of Australia’s most promising healthcare companies. Our focus is on companies at or after Series A, specifically biotech companies at Phase 2 or medical device companies at or after regulatory clearance. Small-molecule Drugs Biological Products Cell & Gene Therapies Medical Devices Diagnostic Technologies AI for Healthcare Healthcare Software / SaaS Data and Analytics

CH

Cathay Health

Cathay Health is dedicated to investing in companies at the convergence of life sciences, healthcare and technology with positive impact on human health. With a reach spanning key bio and tech hubs around the globe, we help companies scale across borders and access new markets, partners and patients. Our Strategy We back venture- and growth-stage companies with emerging technologies that catalyze groundbreaking advances in healthcare. We fund future leaders in tech-enabled medicine with differentiated approaches and strong intellectual property to personalize care, improve access and lower cost. We invest in Series A to C rounds with the ability to lead or co-invest, and help companies scale across borders. Our Focus AreasLife Science Tools Diagnostics Clinical Trial Innovation New Care Models Novel Devices & Materials Enabling Technologies For Advanced Therapies Why Cathay HealthA global platform catalyzing cross-industry collaboration: Cathay Health is affiliated to Cathay Capital – a global investment platform connecting partners and catalyzing collaborations across Europe, North America and Asia to solve the world’s most pressing challenges. Scaling companies to transform health across borders: Our global network and operating expertise across regions allows us to grow impactful companies that serve patients worldwide. Deep expertise in both healthcare and technology: Our unique expertise allows us to identify investment opportunities with the largest impact on human health and care. Investing & operating at the convergence Our team not only invests – but brings operating experience – at the convergence of life sciences, healthcare and tech. Our expertise uniquely bridges these complementary fields to maximize the potential of our portfolio companies.

LR

LRVHealth

We have partnered with disruptive founders as their first institutional investors since 2000. GetWellNetwork, Phressia, Intelycare, Medventive (Change Healthcare), Diameter Health and Verata (Olive) to name a few. OUR MISSIONTo be transformational partners with our strategic LPs and our portfolio companies To deliver superior financial returns To create health and social impact with every investment we make OUR COLLABORATIVE MODEL LRVHealth is the "Inside Healthcare" venture capital platform. Our strategic limited partners include leading provider, payer, and vendor organizations, comprising a network that touches one out of two healthcare consumers across the U.S. This network includes a diverse set of investors across the country representing different geographies, populations, and challenges, and who are all interested and committed to innovation as part of their long-term strategy. LRVHealth pursues venture-stage investments in technology-based businesses in the healthcare sector, including but not limited to software, software-as-a-service, digital health solutions, technology-enabled services, clinical services, diagnostic tools, and medical devices. As an experienced life-cycle investor, the firm actively pursues Seed, Series A, Series B, and Series C stage investments. OUR UNIQUE VALUE LRVHealth is uniquely positioned at the intersection of emerging market disruption patterns and the ongoing challenges and opportunities of incumbent players. Our exclusive focus and value is harnessing this position to connect early stage companies and incumbents to transform healthcare.

GC

Gilmartin Capital

Our focus is on opportunities that are beyond proof of concept and poised for more significant development and growth in the Medical Device, Life Science Tool, Diagnostic and Digital Health sectors. Why Gilmartin Capital? The investing landscape is long on capital and short on insight. Our value extends beyond capital. We possess extensive domain expertise in areas such as strategy, market assessment, and capital markets advisory. Our passion is to avail our experience and network to help you solve problems, drive scientific discovery, help patients and grow. For over two decades, we have amassed a propriety expert network consisting of key opinion leaders across multiple therapeutic verticals and technical specialties, and best-in-class operators in various operational, scientific, and financial areas. In fact, the majority of our fund capital comes from operators like you. The founding partners have decades of experience analyzing and advising healthcare technology companies. We do the math! We want to help you advance your vision.

CH

CRB Health Tech

As a Venture Capital Management firm founded in 2008, we've honed our expertise in Health Technologies: biotech, medical devices and digital health. Founded in 2008 by our seasoned, multi-disciplinary executive team and headquartered in Madrid and Barcelona, we are best positioned to reach most vibrant innovation hubs across Europe. We are at the intersection between… Science and Technology: We harness the power of scientific research and technological innovation to advance healthcare. Ventures and Innovation: We back visionary entrepreneurs and innovative ventures that are transforming the healthcare landscape. Digital and Healthcare: Embracing new digital technologies to enhance people's health.

VC

Vensana Capital

Vensana℠ is actively investing in development and commercial stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, life science tools, and tech-enabled services. WHAT PARTNERSHIP MEANS TO US Vensana℠ places the highest value on partnering with experienced, insightful, and bold management teams. We hope to invest where our capital and commitment amplifies their success.